Effectiveness and risks of cricoid pressure during rapid sequence induction for endotracheal intubation CM Algie, RK Mahar, HB Tan, G Wilson, PD Mahar, J Wasiak Cochrane Database of Systematic Reviews, 2015 | 150 | 2015 |
The Staphylococcus aureus Network Adaptive Platform Trial Protocol: New Tools for an Old Foe SYC Tong, J Mora, AC Bowen, MP Cheng, N Daneman, AL Goodman, ... Clinical Infectious Diseases 75 (11), 2027-2034, 2022 | 62 | 2022 |
Interventions for reducing wrong‐site surgery and invasive clinical procedures CM Algie, RK Mahar, J Wasiak, L Batty, RL Gruen, PD Mahar Cochrane Database of Systematic Reviews, 2015 | 30 | 2015 |
A scoping review of studies using observational data to optimise dynamic treatment regimens RK Mahar, MB McGuinness, B Chakraborty, JB Carlin, MJ IJzerman, ... BMC medical research methodology 21, 1-13, 2021 | 26 | 2021 |
Peer Reviewed: The Joint Effect of Physical Multimorbidity and Mental Health Conditions Among Adults in Australia M Ishida, ESG Hulse, RK Mahar, J Gunn, R Atun, B McPake, N Tenneti, ... Preventing Chronic Disease 17, 2020 | 23 | 2020 |
Anticoagulation strategies in non–critically ill patients with Covid-19 ZK McQuilten, B Venkatesh, V Jha, J Roberts, SC Morpeth, JA Totterdell, ... NEJM Evidence 2 (2), EVIDoa2200293, 2023 | 13 | 2023 |
Lack of transparency in software used to analyze multiple breath washout data RK Mahar, D Vukcevic, L King, JB Carlin, S Ranganathan Pediatric Pulmonology 51 (11), 1108-1110, 2016 | 12 | 2016 |
Statistical analyses of ordinal outcomes in randomised controlled trials: protocol for a scoping review CJ Selman, KJ Lee, CL Whitehead, BJ Manley, RK Mahar Trials 24 (1), 1-7, 2023 | 10 | 2023 |
Early oral antibiotic switch in Staphylococcus aureus bacteraemia: The Staphylococcus aureus Network Adaptive Platform (SNAP) Trial Early Oral Switch Protocol D de Kretser, J Mora, M Bloomfield, A Campbell, MP Cheng, S Guy, ... Clinical Infectious Diseases, ciad666, 2023 | 9 | 2023 |
A randomized trial of nafamostat for Covid-19 SC Morpeth, B Venkatesh, JA Totterdell, GM McPhee, RK Mahar, M Jones, ... NEJM Evidence 2 (11), EVIDoa2300132, 2023 | 6 | 2023 |
TMPRSS2 inhibitors for the treatment of COVID-19 in adults: a systematic review and meta-analysis of nafamostat and camostat mesylate randomised clinical trials MP Hernández-Mitre, SC Morpeth, B Venkatesh, TE Hills, J Davis, ... INPLASY-International Platform of Registered Systematic Review and Meta …, 2023 | 5* | 2023 |
Improving clinical trials using Bayesian adaptive designs: a breast cancer example W Hong, SA McLachlan, M Moore, RK Mahar BMC Medical Research Methodology 22 (1), 133, 2022 | 5 | 2022 |
Transparent reporting of adaptive clinical trials using concurrently randomised cohorts IC Marschner, M Jones, JA Totterdell, RK Mahar, TL Snelling, SYC Tong BMJ medicine 2 (1), 2023 | 4 | 2023 |
Bayesian modelling of lung function data from multiple‐breath washout tests RK Mahar, JB Carlin, S Ranganathan, AL Ponsonby, P Vuillermin, ... Statistics in medicine 37 (12), 2016-2033, 2018 | 4 | 2018 |
Real-world clinical outcomes and cost estimates of metastatic castration-resistant prostate cancer treatment: does sequencing of taxanes and androgen receptor-targeted agents … A Pereira-Salgado, A Anton, F Franchini, RK Mahar, EM Kwan, S Wong, ... Expert review of pharmacoeconomics & outcomes research 23 (2), 231-239, 2023 | 2 | 2023 |
Anticoagulation and Antiplatelet Strategies in Non-Critically Ill Patients with Covid-19 Z McQuilten, B Venkatesh, V Jha, J Roberts, S Morpeth, J Totterdell, ... Blood 140 (Supplement 1), 326-328, 2022 | 2 | 2022 |
A general Bayesian approach to design adaptive clinical trials with time-to-event outcomes JM McGree, AM Overstall, M Jones, RK Mahar arXiv preprint arXiv:2303.00901, 2023 | 1 | 2023 |
Developing and validating a multi-criteria decision analytic tool to assess the value of cancer clinical trials: evaluating cancer clinical trial value P Gillett, RK Mahar, NR Tran, M Rosenthal, M IJzerman Cost Effectiveness and Resource Allocation 21 (1), 87, 2023 | | 2023 |
The Staphylococcus aureus Network Adaptive Platform Trial Protocol: New Tools for an Old Foe (vol 75, pg 2027, 2022) N Anagnostou, S Archuleta, E Athan, L Barina, E Best, M Bloomfield, ... OXFORD UNIV PRESS INC, 2023 | | 2023 |
Outcome-adaptive randomisation in a multi-arm breast cancer trial W Hong, SA McLachlan, M Moore, RK Mahar | | 2022 |